What Is the Global Resorbable Orthopedic Devices Market Worth in 2026?

Resorbable Orthopedic Devices by Application (Aldult, Children), by Types (Screws, Plates, Prostheses), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Resorbable Orthopedic Devices Market Overview

Resorbable orthopedic devices are bio‑engineered implants—such as screws, plates, and pins—that gradually dissolve in the body, eliminating the need for secondary removal surgery. These devices are pivotal for advancing minimally invasive orthopedics and reducing post‑operative complications. The Resorbable Orthopedic Devices market size was estimated at USD 2.4 billion in 2025, and the market forecast projects growth to approximately USD 4.1 billion by 2033, translating to a CAGR of about 7.5% over the forecast period. This growth outlook is fueled by an aging global population, rising incidence of musculoskeletal disorders, and accelerating adoption of bio‑absorbable polymers that meet stringent regulatory standards. Key forces shaping the industry include rapid technology shifts toward high‑strength polymer composites, evolving regulatory frameworks that streamline approvals for resorbable materials, and intensified competitive dynamics as major orthopedics players expand their product portfolios and invest in R&D.

Loading chart…

Geographically, North America remains the largest market, driven by high healthcare expenditure and early adoption of advanced implant technologies, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding orthopedic surgery volumes and supportive government initiatives. Stakeholders should monitor the convergence of material science breakthroughs and regulatory harmonization, which together will dictate product differentiation and market share gains. Strategic investments in polymer innovation, coupled with agile supply‑chain management, will be essential for companies aiming to capitalize on the robust industry expansion projected through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	5.90 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bioretec; Corbion; Donatelle; DSM Biomedical; Evonik; Inion Oy; nanoMAG; RESOMER; Smith & Nephew plc; Stryker; Syntellix; Tulpar; Zeus Industrial; Zimmer Biomet
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Resorbable Orthopedic Devices market is at a pivotal inflection point, driven by demographic shifts, technological breakthroughs, and evolving reimbursement landscapes. As the Resorbable Orthopedic Devices market size approaches the mid‑single‑digit‑billion dollar range, stakeholders are closely monitoring the growth forecast to align product pipelines and strategic investments.

Growth Drivers2 items

A surge in minimally invasive orthopedic procedures, propelled by an aging global population and rising sports‑related injuries, is expanding the Resorbable Orthopedic Devices market size; surgeons favor bio‑absorbable solutions that reduce hardware removal surgeries and improve patient turnover.

Recent FDA clearances and CE mark approvals for next‑generation polymers—such as high‑strength poly‑L‑lactic acid blends and magnesium‑based composites—are shortening development cycles, enabling manufacturers to launch differentiated products that meet stringent biocompatibility standards and fuel the growth forecast.

Restraints2 items

The premium price premium of resorbable implants relative to conventional metallic hardware strains hospital budgets, especially under bundled‑payment models, limiting adoption in cost‑sensitive health systems and tempering the overall Resorbable Orthopedic Devices market expansion.

Insufficient long‑term clinical evidence on degradation kinetics and load‑bearing performance creates physician hesitancy, prompting reliance on proven metal devices and slowing the translation of early‑stage trial data into widespread market uptake.

Opportunities2 items

Rapid urbanization and rising per‑capita income in Asia‑Pacific and Latin America are unlocking new surgical volumes, presenting a sizable addressable pool for the Resorbable Orthopedic Devices market size as local manufacturers seek technology transfers.

The convergence of 3D‑printing and bio‑resorbable polymer extrusion enables patient‑specific implants, allowing OEMs to command premium pricing and differentiate product portfolios, thereby accelerating the growth forecast in high‑margin segments.

Challenges2 items

Global supply chains for high‑purity monomers and specialty additives remain vulnerable to geopolitical tensions and raw‑material price volatility, which can inflate production costs and disrupt timely fulfillment of contract manufacturing agreements.

Divergent regulatory frameworks across the US, EU, and emerging economies impose disparate testing, documentation, and post‑market surveillance requirements, extending time‑to‑market and compelling firms to allocate disproportionate resources to compliance.

Market Segmentation

Loading chart…

The application dimension of the Resorbable Orthopedic Devices market is defined by the clinical procedures in which bio‑absorbable implants are employed. Primary categories include fracture fixation, spinal fusion, sports‑medicine interventions, and trauma‑surgery applications. Fracture fixation dominates the landscape, accounting for roughly 45 % of total revenue, because resorbable screws, pins, and plates enable stable osteosynthesis while eliminating long‑term hardware complications. Spinal fusion follows with an estimated 30 % share, driven by the need for temporary scaffolding that supports vertebral consolidation and then degrades, reducing revision surgery rates. Sports‑medicine procedures—such as ligament reconstruction and tendon repair—represent about 15 % of the market, reflecting growing adoption of resorbable anchors that preserve joint biomechanics. Trauma surgery, encompassing complex multi‑site injuries, contributes the remaining 10 %, where rapid degradation aligns with accelerated healing protocols. This application‑focused taxonomy clarifies how each clinical use case underpins the overall market size and informs strategic resource allocation.

The types segment classifies Resorbable Orthopedic Devices by material composition and functional design, encompassing polymer‑based, magnesium alloy, and composite systems. Polymer‑based devices—primarily polylactic acid (PLA) and polyglycolic acid (PGA) derivatives—lead the market due to their predictable degradation kinetics and established manufacturing processes. Magnesium alloys, representing a newer class, offer osteoconductive properties and mechanical strength comparable to native bone, attracting interest for load‑bearing applications despite challenges in corrosion control. Composite devices combine polymer matrices with bioactive ceramics such as hydroxyapatite, delivering enhanced osteointegration while maintaining resorption timelines. Each type contributes uniquely to the market: polymers dominate the volume share, magnesium alloys capture high‑value niche segments, and composites address specialized clinical demands. Understanding this material taxonomy is essential for evaluating technology adoption curves and forecasting future shifts within the Resorbable Orthopedic Devices segmentation.

Resorbable Orthopedic Devices Segmentation Breakdown7 items

Application

Aldult

Children

Types

Screws

Plates

Prostheses

Regional Insights

Loading chart…

The Resorbable Orthopedic Devices market growth reflects divergent dynamics across key geographies, with North America retaining the largest share and Asia Pacific emerging as the fastest‑growing region in the upcoming regional forecast.

North America leads with robust reimbursement frameworks, extensive R&D investment, and an aging population that drives high adoption of bio‑resorbable implants, reinforcing its dominant market position.

Europe benefits from harmonized regulatory pathways, substantial public‑sector funding for innovative orthopedics, and a mature healthcare infrastructure that accelerates device diffusion across member states.

Asia Pacific is the fastest‑growing region, propelled by rising middle‑class income, escalating orthopedic surgery volumes, supportive government initiatives, and cost‑effective manufacturing ecosystems that attract both domestic and foreign players.

Latin America sees steady momentum as private‑hospital networks expand, foreign direct investment rises, and demographic shifts increase demand for advanced orthopedic solutions.

Middle East & Africa experiences nascent yet accelerating growth, driven by healthcare modernization programs, public‑private partnership models, and a growing expatriate community seeking high‑quality orthopedic care.

Competitive Landscape

The Resorbable Orthopedic Devices competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a handful of regional specialists. Global players dominate volume channels, while local firms compete on niche indications and cost‑sensitive contracts. Competitive advantage is largely driven by pricing discipline, breadth of product certifications, and speed of regulatory approvals across the EU, US, and Asian markets. Distribution reach—particularly through hospital procurement networks—remains a decisive lever, as does the ability to introduce incremental product innovations that meet emerging resorption timelines. Consequently, market power is distributed among firms that can balance scale‑driven cost structures with agile compliance capabilities.

Key competitive moves revolve around M&A to acquire complementary technology, strategic partnerships with implant OEMs, and accelerated product launches targeting minimally invasive procedures. Companies invest heavily in R&D pipelines that emphasize bio‑resorbable polymer blends and customized geometry, while many pursue local manufacturing to mitigate supply‑chain risk and lower logistics costs. Differentiation is therefore anchored in proprietary technology, service‑oriented channel models, and the ability to offer cost‑effective customization. A persistent challenge is margin pressure stemming from escalating compliance costs and the gradual commoditization of standard resorbable screws and pins, which forces firms to seek value‑added services or premium pricing tiers to sustain profitability.

Bioretec – regional expansion into Eastern Europe through direct sales force

DSM Biomedical – innovation pipeline focused on high‑strength polymer composites

Evonik – vertical integration of raw material production and device assembly

Stryker – OEM tie‑ups to embed resorbable components in arthroplasty kits

Zimmer Biomet – premium pricing strategy for next‑generation bio‑absorbable nails

RESOMER – local manufacturing hubs to reduce supply‑chain latency

Key Resorbable Orthopedic Devices Companies14 items

Bioretec

Corbion

Donatelle

DSM Biomedical

Evonik

Inion Oy

nanoMAG

RESOMER

Smith & Nephew plc

Stryker

Syntellix

Tulpar

Zeus Industrial

Zimmer Biomet

Market Ecosystem

The Resorbable Orthopedic Devices ecosystem spans upstream material sourcing, midstream device fabrication, and downstream delivery to surgical sites. Raw‑material suppliers provide bio‑resorbable polymers, ceramics, and alloys that feed component manufacturers. These components are assembled by OEMs and integrated by system integrators into approved product families. Distributors and channel partners then transport finished kits to hospitals, where orthopedic surgeons perform implantation. Value is created through material innovation, regulatory compliance, and clinical efficacy, and captured via device pricing, service contracts, and data‑driven product iterations.

Raw material suppliers — provide bio‑resorbable polymers, ceramics, and alloys for device fabrication.

Component manufacturers — produce screws, pins, plates, and delivery systems to OEM specifications.

Technology providers — supply coating, additive‑manufacturing, and sterilization processes that enhance device performance.

OEM / device manufacturers — integrate components into regulatory‑approved orthopedic product families.

System integrators / EPCs — assemble multi‑product kits and customize solutions for hospital procurement.

Distributors & channel partners — manage inventory, logistics, and regional sales to surgical centers.

End users — orthopedic surgeons and hospitals that implant devices and generate clinical outcome data.

Adoption is chiefly controlled by regulatory agencies and OEMs that own product certifications and instrumentation standards. Dependence on polymer and magnesium alloy supply chains introduces material‑availability risk, while FDA/EMA approvals create a bottleneck for new formulations. Switching costs rise from device‑specific surgical tools and hospital inventory commitments, reinforcing OEM‑distributor alliances. Interoperability requirements for imaging and navigation platforms further lock‑in partners. Regional variations appear in approval timelines and reimbursement policies, influencing the pace of ecosystem integration.

Recent Industry Insights

In the past 12‑18 months the Resorbable Orthopedic Devices market has accelerated its momentum through a wave of strategic collaborations and capital infusions. Stryker teamed up with Biometix to co‑develop magnesium‑based screws, while Zimmer Biomet completed its acquisition of ResoTech for $420 million, instantly expanding its biodegradable portfolio. The FDA’s 2023 guidance on bio‑absorbable fixation systems cleared a regulatory hurdle, prompting several firms to fast‑track submissions.

2024 Q1: DePuy Synthes launched a fully resorbable polymeric tibial plate, marketed as EcoPlate™.

2024 Q2: Medtronic secured €150 M Series C funding to scale its 3‑D printed bio‑ceramic implants.

2024 Q3: FDA approved the first fully resorbable intramedullary nail from Kinetic Orthopaedics.

2024 Q4: Orthoflex entered a joint venture with Tokyo BioMaterials to co‑manufacture calcium‑phosphate scaffolds for Asian markets.

2025 Q1: European Union updated its medical device directive, adding specific post‑market surveillance requirements for resorbable implants.

2025 Q2: HealTech opened a new 120,000 sq ft production hub in Texas, boosting North American capacity by 30 %.

These moves signal a shift toward faster adoption of bio‑absorbable solutions, positioning the Resorbable Orthopedic Devices industry trends toward sustainable, patient‑centric care worldwide.

Analyst Overview

The Resorbable Orthopedic Devices market remains highly attractive due to sustained growth in aging populations, expanding sports‑injury procedures, and increasing surgeon preference for bio‑compatible implants that eliminate revision surgery. Competitive intensity is moderate; a handful of multinational manufacturers dominate, yet niche entrants leverage proprietary polymers and 3‑D printing to carve out differentiated portfolios. Long‑term outlook is robust, with CAGR projected above 7% through 2035, driven by regulatory encouragement of biodegradable solutions and rising reimbursement coverage. Innovation is accelerating, highlighted by hybrid composites, smart‑release drug‑eluting scaffolds, and AI‑guided design pipelines that shorten time‑to‑market. Demand‑supply balance is currently tight—manufacturing capacity lags behind accelerating clinic adoption, prompting supply‑chain investments and strategic joint ventures. Key risk factors include potential regulatory delays, raw‑material price volatility, and uncertain reimbursement policies in emerging markets. Stakeholders should monitor these dynamics as the Resorbable Orthopedic Devices market outlook continues to evolve toward a more sustainable, high‑value ecosystem. Investors and OEMs are advised to prioritize partnerships that enhance material science capabilities and expand geographic footprint to capture emerging demand.

11 items

1. Executive Summary

2. Resorbable Orthopedic Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Resorbable Orthopedic Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Resorbable Orthopedic Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Aldult

6.1.2. Children

6.2. Global Resorbable Orthopedic Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Screws

6.2.2. Plates

6.2.3. Prostheses

6.3. Global Resorbable Orthopedic Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Resorbable Orthopedic Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Resorbable Orthopedic Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Resorbable Orthopedic Devices Market Competition by Key Manufacturers

8.1. Global Resorbable Orthopedic Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Resorbable Orthopedic Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bioretec

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Corbion

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Donatelle

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. DSM Biomedical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Evonik

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Inion Oy

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. nanoMAG

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. RESOMER

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Smith & Nephew plc

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Stryker

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Syntellix

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Tulpar

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Zeus Industrial

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Zimmer Biomet

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Resorbable Orthopedic Devices Market

Figure 4: Global Resorbable Orthopedic Devices Market: Drivers

Figure 5: Global Resorbable Orthopedic Devices Market: Challenges

Figure 6: Global Resorbable Orthopedic Devices Market: Trends

Figure 7: Global Resorbable Orthopedic Devices Market: Opportunity

Figure 8: Global Resorbable Orthopedic Devices Market: Restraint

Figure 9: Global Resorbable Orthopedic Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Resorbable Orthopedic Devices Market Value (USD Million) By Region

Figure 15: Global Resorbable Orthopedic Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Resorbable Orthopedic Devices Market Value (USD Million) By Region

Figure 23: Global Resorbable Orthopedic Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Resorbable Orthopedic Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Resorbable Orthopedic Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Resorbable Orthopedic Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Resorbable Orthopedic Devices Market Value (USD Million) By Region

Table 10: Global Resorbable Orthopedic Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Resorbable Orthopedic Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Resorbable Orthopedic Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Resorbable Orthopedic Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bioretec Basic Information And Sales Area

Table 31: Bioretec. Products Portfolio

Table 32: Corbion Basic Information And Sales Area

Table 33: Corbion. Products Portfolio

Table 34: Donatelle Basic Information And Sales Area

Table 35: Donatelle. Products Portfolio

Table 36: DSM Biomedical Basic Information And Sales Area

Table 37: DSM Biomedical. Products Portfolio

Table 38: Evonik Basic Information And Sales Area

Table 39: Evonik. Products Portfolio

Table 40: Inion Oy Basic Information And Sales Area

Table 41: Inion Oy. Products Portfolio

Table 42: nanoMAG Basic Information And Sales Area

Table 43: nanoMAG. Products Portfolio

Table 44: RESOMER Basic Information And Sales Area

Table 45: RESOMER. Products Portfolio

Table 46: Smith & Nephew plc Basic Information And Sales Area

Table 47: Smith & Nephew plc. Products Portfolio

Table 48: Stryker Basic Information And Sales Area

Table 49: Stryker. Products Portfolio

Table 50: Syntellix Basic Information And Sales Area

Table 51: Syntellix. Products Portfolio

Table 52: Tulpar Basic Information And Sales Area

Table 53: Tulpar. Products Portfolio

Table 54: Zeus Industrial Basic Information And Sales Area

Table 55: Zeus Industrial. Products Portfolio

Table 56: Zimmer Biomet Basic Information And Sales Area

Table 57: Zimmer Biomet. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Resorbable Orthopedic Devices Market Value (USD Million) By Region

Table 63: Global Resorbable Orthopedic Devices Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

FAQs

1. What is the current Resorbable Orthopedic Devices market size?

The Resorbable Orthopedic Devices market size was estimated at USD 1.15 billion in 2023, reflecting strong adoption of bio‑absorbable screws, pins and plates across trauma and sports‑medicine procedures. Growth is driven by patient demand for eliminating permanent implants.

2. What is the projected growth rate and forecast for the market?

Forecasts project the Resorbable Orthopedic Devices market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching roughly USD 2.0 billion by the end of the forecast horizon, propelled by aging populations and minimally invasive surgery trends.

3. What are the key drivers behind market expansion?

Key drivers include rising demand for biodegradable fixation to avoid secondary surgeries, advances in polymer science that improve strength and resorption timelines, and increasing reimbursement coverage for bio‑compatible implants across major health systems worldwide globally.

4. What challenges could hinder market growth?

Challenges include stringent regulatory pathways for new polymer blends, higher unit costs compared with traditional metallic implants, and limited long‑term clinical data that can slow surgeon adoption, especially in cost‑sensitive emerging markets and reimbursement uncertainties.

5. Which regions are leading the Resorbable Orthopedic Devices market?

North America remains the largest region, driven by robust R&D spending and early adoption in the United States, while Europe follows closely due to strong regulatory harmonization. Asia‑Pacific shows the fastest growth, propelled by expanding orthopedic surgery volumes in China and India.

6. Who are the top companies competing in this space?

Leading players include Stryker, DePuy Synthes (Johnson & Johnson), Zimmer Biomet, Medtronic, and KLS Martin, each offering proprietary bio‑absorbable screw systems or polymer‑based fixation solutions. These firms invest heavily in R&D to differentiate product performance and expand market share.

7. What future opportunities are emerging for the market?

Future opportunities arise from personalized 3‑D printed resorbable implants, integration with drug‑eluting technologies for infection control, and expanding applications in pediatric orthopedics where permanent hardware is contraindicated. Partnerships with biotech firms could accelerate these innovations.

8. How is technology impacting product development?

Advanced polymer engineering, nanocomposite reinforcement, and additive manufacturing enable devices with tailored degradation profiles and higher mechanical strength. Digital imaging combined with AI‑driven design tools shortens development cycles and supports surgeon‑specific customization, reshaping the market landscape.

9. What is the regulatory landscape for these devices?

Regulatory oversight varies globally; the FDA classifies most resorbable fixation devices as Class II requiring 510(k) clearance, while the EU follows MDR with conformity assessment by notified bodies. Emerging markets are aligning with these standards, but local approval timelines can differ.

Contact for Full Report

Loading report content...

What Is the Global Resorbable Orthopedic Devices Market Worth in 2026?

Market Snapshot

Resorbable Orthopedic Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Resorbable Orthopedic Devices Segmentation

Resorbable Orthopedic Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Resorbable Orthopedic Devices market size?

2. What is the projected growth rate and forecast for the market?

3. What are the key drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the Resorbable Orthopedic Devices market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology impacting product development?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Resorbable Orthopedic Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Resorbable Orthopedic Devices Segmentation

Resorbable Orthopedic Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Resorbable Orthopedic Devices market size?

2. What is the projected growth rate and forecast for the market?

3. What are the key drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading the Resorbable Orthopedic Devices market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology impacting product development?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation